Ho-Cheol Kang ESA-SRB-ANZBMS 2024 in conjunction with ENSA

Abstracts this author is presenting:

• Durable and dramatic response to immune checkpoint inhibitors in a patient with ACTH-secreting pituitary carcinoma: A 27-month follow-up study — ESA Poster Listing: Clinical Cases